SJ , - I too like Mr Chen questions , but looks to me that good questions is not the same as good analyses IMO..

Our BLA is delayed for one month , and from this ridiculous price of 1.50 , he goes to more ridiculous of 1.00 , over 33% down ???

I am sorry SJ , knowing how many drug resistant HIV patients are in USA and globally , thinking that we have most probably best PrEP drug globally , and all of this will happen within one year , and giving this company
600 - 700 Mill value is not a good analysis IMO.

I am not talking even mono in HIV or cancers or GvHD , MS and any other disease.

Sorry , but in no way I can agree with this analysis !!!!!

I think I will apply for a job of analyst or adviser in some biotech...maybe Gilead , I see they need help very badly now .


All IMO of course.